Your browser doesn't support javascript.
loading
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors.
Doi, Toshihiko; Shitara, Kohei; Kojima, Takashi; Kuboki, Yasutoshi; Matsubara, Nobuaki; Bando, Hideaki; Yoh, Kiyotaka; Naito, Yoichi; Hirai, Hiroshi; Kurokawa, Yukinori; Kato, Terufumi; Morizane, Chigusa.
Affiliation
  • Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kojima T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Naito Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Hirai H; Department of Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kurokawa Y; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kato T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd., Tsukuba, Japan.
  • Morizane C; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Cancer Sci ; 114(2): 574-585, 2023 Feb.
Article in En | MEDLINE | ID: mdl-35838190
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Protein Kinase Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Sci Year: 2023 Type: Article Affiliation country: Japan